Nature-based Therapy Program for Parkinson's Disease (PARC)
Trial
N/A
Completed
Nov. 4, 2026
Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease
Trial
N/A
Completed
Nov. 4, 2026
Visuospatial and Affective Abilities in Parkinson Disease
Trial
N/A
Enrolling by invitation
Nov. 4, 2026
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Trial
Phase 3
Recruiting
Nov. 4, 2026
PET Scanning in Parkinson s Disease
Trial
N/A
Completed
Nov. 4, 2026
Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
Trial
Phase 1
Recruiting
Nov. 4, 2026
Physiological Investigations of Movement Disorders
Trial
N/A
Completed
Nov. 4, 2026
Longitudinal Observation of Neurodegeneration in Parkinson's Disease Using Molecular Imaging and Blood Biomarkers
Trial
N/A
Not yet recruiting
Nov. 4, 2026
Accelerated rTMS for Apathy in Parkinson's Disease
Trial
N/A
Recruiting
Nov. 4, 2026
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
Trial
Phase 2
Completed
Nov. 3, 2026
Efficacy of Split Gait in the Treatment of Dynamic Asymmetries in Subjects With Pathologic Claudication
Trial
N/A
Completed
Nov. 3, 2026
MR-guided Focused Ultrasound Plus GCase
Trial
N/A
Active, not recruiting
Nov. 3, 2026
Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease
Trial
Phase 1
Recruiting
Nov. 3, 2026
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Trial
N/A
Recruiting
Nov. 3, 2026
AAV2-hAADC for Parkinson's Disease (PDCS-01)
Trial
Phase 1
Not yet recruiting
Nov. 2, 2026
Non-invasive Vagus Nerve Stimulation for Parkinson's Disease
Trial
N/A
Not yet recruiting
Nov. 2, 2026
Genotypic Influences on Network Progression in Parkinson's Disease
Trial
N/A
Completed
Nov. 2, 2026
Neuroplasticity in Parkinson's Disease
Trial
N/A
Completed
Nov. 2, 2026
Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models
Trial
N/A
Recruiting
Nov. 2, 2026